U.S. markets open in 1 hour 24 minutes

IDEAYA Biosciences, Inc. (IDYA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
26.47+1.09 (+4.29%)
At close: 4:00PM EDT
Show:
Balance Sheet
Cash Flow
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Breakdown
ttm
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Total Revenue
35,541
19,538
0
0
0
Operating Expense
66,003
54,882
44,271
36,417
14,438
Operating Income
-30,462
-35,344
-44,271
-36,417
-14,438
Net Non Operating Interest Income Expense
433
849
2,288
1,994
150
Other Income Expense
-
-
8
77
2,426
Pretax Income
-30,029
-34,495
-41,975
-34,346
-11,862
Net Income Common Stockholders
-30,029
-34,495
-41,975
-34,416
-11,862
Diluted NI Available to Com Stockholders
-30,029
-34,495
-41,975
-34,416
-11,862
Basic EPS
-
-1.40
-3.36
-2.61
-0.83
Diluted EPS
-
-1.40
-3.36
-2.61
-0.83
Basic Average Shares
-
24,722
12,497
13,165
14,241
Diluted Average Shares
-
24,722
12,497
13,165
14,241
Total Operating Income as Reported
-30,462
-35,344
-44,271
-36,417
-14,438
Total Expenses
66,003
54,882
44,271
36,417
14,438
Net Income from Continuing & Discontinued Operation
-30,029
-34,495
-41,975
-34,346
-11,862
Normalized Income
-30,029
-34,495
-41,975
-34,346
-11,862
Interest Income
433
849
2,288
1,994
150
Net Interest Income
433
849
2,288
1,994
150
EBIT
-30,462
-35,344
-44,271
-36,417
-14,438
EBITDA
-28,928
-
-
-
-
Reconciled Depreciation
1,534
1,381
1,245
886
391
Net Income from Continuing Operation Net Minority Interest
-30,029
-34,495
-41,975
-34,346
-11,862
Normalized EBITDA
-28,928
-33,963
-43,026
-35,531
-14,047
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0